Why Founders with MD/PhDs Build Differently
The clinical lens changes how founders prioritize, what they validate first, and who they hire. It's not a credential — it's a way of thinking.
Navigating Your First FDA 510(k) Without a Regulatory Team
What first-time device founders typically get wrong about the 510(k) process — and what actually moves submissions forward.
The New Reimbursement Landscape for Digital Health in 2026
CMS updates and payor shifts are opening doors that were closed two years ago. Here's what changed and what it means for founders.
Why AI Diagnostics Need More Than a Validation Study
A strong AUC doesn't answer the questions hospitals and payors are actually asking. The evidentiary bar is higher than most founders expect.
What Series A Healthcare Metrics Actually Look Like
Forget generic SaaS benchmarks. Healthcare Series A diligence looks at different numbers — and the signal investors want to see is different too.
Five Fundraising Mistakes Biotech Founders Keep Making
From misjudging the diligence timeline to pitching the wrong milestones, these are the patterns we see repeatedly in biotech fundraising.
Regulatory Strategy Is a Competitive Advantage
Companies that invest early in understanding their regulatory pathway end up with a moat. The ones that treat it as overhead often don't make it.
Patient Outcomes as the North Star: Moving Past Vanity Metrics
DAUs and NPS scores feel real until you're in a hospital contract negotiation. The metrics that matter most in healthcare are the ones closest to the patient.
The CRISPR Investment Horizon: What We're Watching
Three years after the first approved CRISPR therapy, the field has matured in ways that change the investment calculus significantly.
How to Build a Clinical Advisory Board That Actually Works
Most clinical advisory boards are resume decoration. The ones that add real value are structured differently from the start.
Remote Monitoring Reimbursement: The CPT Codes That Changed Everything
A handful of CPT code updates in the past two years created a real reimbursement pathway for remote monitoring that simply didn't exist before.
From Seed to Series A in Digital Health: A 24-Month Roadmap
The milestones that move digital health companies from early traction to a credible Series A — based on what we've seen work across our portfolio.